Fresenius SE & Co KGaA (EUR)
FRE
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range42.22 | 43.13
52-Wk Range- | -
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINDE0005785604
Volume816,141.00
Exchange VenueETR

Company Profile

Fresenius SE & Co KGaA is a holding company engaged in healthcare business. It provides dialysis machines, and manufactures equipment for Medical Care through its subsidiaries. The company also manufactures IV drugs, clinical nutrition, and infusion.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)6.78
EPS Growth (3 year avg)0.05
Operating Margin % 13.00
Net Margin %5.32
Return on Equity11.70
Debt/Equity1.62

Documents

Annual Report
en 31/12/2019

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)23,231.0027,626.0029,083.0033,886.0033,530.0035,409.00
Operating Income (m)3,114.003,875.004,327.004,589.004,442.004,602.00
Net Income (m)1,067.001,358.001,593.001,814.002,027.001,883.00
Basic EPS1.972.502.923.273.653.38
Avg. Diluted Shares Outstanding (m)544.30548.16550.08557.51557.30557.42
Balance Sheet
EUR201420152016201720182019
Current Assets (m)10,028.0010,917.0011,799.0012,604.0014,790.0015,264.00
Non Current Assets (m)29,869.0032,253.0034,648.0040,529.0041,913.0051,742.00
Total Assets (m)39,897.0043,170.0046,447.0053,133.0056,703.0067,006.00
Current Liabilities (m)7,104.007,409.008,544.0010,665.0013,275.0013,884.00
Total Liabilities (m)------
Total Equity (m)9,335.0010,935.0012,503.0013,661.0015,411.0016,778.00
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)2,585.003,327.003,574.003,937.003,742.004,263.00
Capital Expenditure (m)-1,345.00-1,489.00-1,628.00-1,823.00-2,149.00-2,459.00
Figures are quoted in EUR unless stated otherwise
42.44
Last Price